Search
  • Search


    Finland: Tenders/HUS-yhtymä/Test for amino acids in plasma and urine
    1. Competition notice published

      Jul 30, 4:28 AMJuly 30, 2026 4:28 AM
    2. Questions deadline

      Aug 19, 9:00 AMAugust 19, 2026 9:00 AM
    3. Tender submission deadline

      Aug 31, 9:00 AMAugust 31, 2026 9:00 AM
    4. Opening date

      Aug 31, 9:15 AMAugust 31, 2026 9:15 AM
    5. Result notice published

      Sep 7, 6:34 AMSeptember 7, 2026 6:34 AM
    6. Tender validity period

      May 31, 2027 9:00 AMMay 31, 2027 9:00 AM

    Brief

    Test for amino acids in plasma and urine

    Cancelled

    The competition has been cancelled.

    Award
    Price only
    Procedure
    OpenSingle stage
    Agreement
    Buying goodsover 4 years

    Brief

    HUS Group has cancelled a tender for the procurement of test kits for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology, as no offers, requests to participate, or projects were received. The kits were intended for the detection and quantitative analysis of amino acids in plasma and urine, covering both plasma and urine testing, with an estimated annual volume of approximately 1000 plasma and 200 urine patient sample tests. The contract period was set for 4 years. The required technology included LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions.

    Laboratorie- og analyseutstyr

    Result

    TED
    • Reason for cancellation
      Ingen tilbud, forespørsler å delta eller prosjekter er mottatt
    • Number of bids
      0

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Award Criteria

    • Description

      Hinta

      Source

      No source found in the documents. Check the weight against the tender documents.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at HUS-yhtymä

    From the notice

    • The HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender. This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch. Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.Main features of the procedureThe procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. PROCESSING OF TENDERS The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English. PARTIAL TENDERS Partial tenders will not be accepted. PARALLEL TENDERS Parallel tenders are not permitted.

    • Contact

      Investments and diagnostics categorykilpailutus.diagnostiikka@hus.fi
    • Type
      Result
    • Main code
      Medical equipments, pharmaceuticals and personal care products
      33000000
    • 33696200Blood-testing reagents33696500Laboratory reagents33696700Urological reagents

    Similar active competitions

    • HUS-yhtymä

      Laboratorie- og analyseutstyr

      MLPA-Based CNV Testing for BRCA1/BRCA2

      HUS Group, the joint authority for Helsinki and Uusimaa, needs an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licenses, and other components required for routine use and generation of reportable patient results. The contract period is 2 years, after which it continues indefinitely until terminated. The estimated annual consumption is approximately 1600 reportable patient samples, to be delivered to the HUSLAB Laboratory of Genetics in Helsinki-Uusimaa, Finland. The award criterion is the lowest total comparison price.

      Competition
      Nov 9, 2026(10 days)
    • Fimlab Laboratoriot Oy

      Laboratorie- og analyseutstyr

      Näytteenottoputket ja virtsanäyteastia

      Fimlab Laboratoriot Oy tarvitsee näytteenottoputkia, näytteen erottelussa käytettäviä putkia, virtsanäyteastioita ja virtsansiirtoadaptereita toiminta-alueensa (Kanta-Hämeen, Keski-Suomen, Pirkanmaan, Pohjanmaan ja Päijät-Hämeen hyvinvointialueet) tarpeisiin. Sopimuksen arvioitu kokonaisarvo on enintään 7 miljoonaa euroa, ja sen suunniteltu kesto on 2 vuotta, jonka jälkeen sitä on mahdollista jatkaa toistaiseksi voimassa olevana. Hankinta on jaettu 20 osa-alueeseen, ja jokaiseen osa-alueeseen valitaan yksi toimittaja. Tietyissä osa-alueissa on pakollisena optiona valmiiksi viivakoodattuja putkityyppejä. Tarvikkeiden jakelu tapahtuu hyvinvointialueiden logististen toimijoiden tai Fimlabin oman oston kautta. Tarjoukset arvioidaan hinnan (42.8571% tai 47.619%) ja laadun (4.7619% tai 4.7619%) perusteella. Fisher Scientific Oy, Mediq Suomi Oy, OneMed Oy, Pamark Business Oy, Suomen MediTuote Oy, Becton Dickinson Finland Oy, Triolab Oy, Steripolar Oy, Mekalasi Oy, Pedihealth Oy, VWR International Oy, Oy Vestek Ab ja Sarstedt Oy ovat toimittaneet vastaavia laboratoriotarvikkeita aiemmin.

      Competition
      Nov 9, 2026(10 days)
      €7,000,000
    • Varsinais-Suomen hyvinvointialue

      Helse- og sosial tjenesteyting

      Laboratoriotutkimuspalvelut

      Varsinais-Suomen hyvinvointialue tarvitsee laboratoriotutkimuspalveluita, joiden kokonaisarvo on enintään 4,04 miljoonaa euroa. Tarjoukset käsitellään kolmessa vaiheessa: tarjoajien soveltuvuuden arviointi, tarjousten tarjouspyynnön mukaisuuden arviointi ja tarjousten kokonaistaloudellisuuden vertailu. Tarjoukset arvioidaan halvimman hinnan perusteella. Tarjoajien on laadittava tarjoukset suomen kielellä.

      Competition
      Nov 26, 2026(27 days)
      €4,040,000